TMUNITY THERAPEUTICS
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors... . The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.
TMUNITY THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Manufacturing Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.tmunity.com
Total Employee:
51+
Status:
Active
Contact:
215-966-1600
Total Funding:
230 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
Current Advisors List
Current Employees Featured
Founder
Investors List
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Tmunity Therapeutics
BrightEdge Fund
BrightEdge Fund investment in Series B - Tmunity Therapeutics
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program investment in Series B - Tmunity Therapeutics
Westlake Village BioPartners
Westlake Village BioPartners investment in Series B - Tmunity Therapeutics
Be The Match BioTherapies
Be The Match BioTherapies investment in Series B - Tmunity Therapeutics
University of Pennsylvania
University of Pennsylvania investment in Series B - Tmunity Therapeutics
Gilead Sciences
Gilead Sciences investment in Series B - Tmunity Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - Tmunity Therapeutics
Be The Match BioTherapies
Be The Match BioTherapies investment in Series A - Tmunity Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series A - Tmunity Therapeutics
Official Site Inspections
http://www.tmunity.com Semrush global rank: 8.56 M Semrush visits lastest month: 290
Unable to get host informations!!!
More informations about "Tmunity Therapeutics"
Tmunity Therapeutics - Crunchbase Company Profile
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications.See details»
Company: Tmunity Therapeutics - CRISPR Medicine
Tmunity Therapeutics is a privately held biotherapeutics company focused on developing the next generation of T cell therapies. Tmunity is working closely with the University of Pennsulvania, where the company was founded.See details»
Tmunity 2025 Company Profile: Valuation, Investors, …
Information on acquisition, funding, cap tables, investors, and executives for Tmunity. Use the PitchBook Platform to explore the full profile.See details»
Tmunity Therapeutics Incorporated | LinkedIn
Tmunity Therapeutics Incorporated | 10,333 followers on LinkedIn. Tmunity is now part of Kite, a Gilead Company. | Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell …See details»
Tmunity Therapeutics Inc - Company Profile and News
Company profile page for Tmunity Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Tmunity Therapeutics - VentureRadar
Website: https://www.tmunity.com. Develops next-generation T-cell immunotherapies for patients with devastating diseases, partnering with leading institutions and utilizing cutting-edge …See details»
Tmunity Therapeutics - 2025 Company Profile - Tracxn
Mar 26, 2025 Tmunity Therapeutics - Leveraging the immunological potential of T cells to treat a wide range of diseases. Raised a total funding of $231M over 6 rounds from 11 investors. …See details»
Tmunity's Leadership Team Team - Team members and org chart
About. Tmunity's Leadership Team includes Vijay Reddy and 2 others. Team members. David M. Barrett. VP, Translation ResearchSee details»
Tmunity Therapeutics (USA) Funding: $230M - Medical Startups
Apr 24, 2025 USA | Funding: $230M Website: https://www.tmunity.com Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full …See details»
Tmunity Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Mar 5, 2025 Tmunity Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Tmunity Therapeutics CEO and Key Executive Team | Craft.co
Tmunity Therapeutics's Director is Patrick Gray. Other executives include Judith Li, Director; Jeffrey Leiden, Non-Executive Chairman and 8 others. See the full leadership team at Craft.See details»
Tmunity Therapeutics - Company info. interviews, news
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications.See details»
Tmunity’s Competitors, Revenue, Number of Employees, Funding …
Tmunity’s Profile, Revenue and Employees. Tmunity is a Pennsylvania-based biotechnology company that researches and develops cell therapies for the treatment of cancer. Tmunity’s …See details»
Tmunity Therapeutics Is Pioneering Personalized Cancer Treatments
Oct 14, 2019 With the combined expertise of leading gene and cell therapy researchers, Tmunity is developing the next wave of immunotherapies for cancer and other diseases.See details»
Tmunity Therapeutics - Overview, News & Similar companies
Dec 24, 2022 Who is Tmunity Therapeutics. Founded in 2015 and headquartered in Philadelphia, Pennsylvania, Tmunity Therapeutics is a private clinical-stage biotherapeutics …See details»
Unity ID
Unity is the ultimate game development platform. Use Unity to build high-quality 3D and 2D games, deploy them across mobile, desktop, VR/AR, consoles or the Web, and connect with …See details»
Tmunity nabs $100M for next-gen T-cell immunotherapies
Jan 23, 2018 Tmunity Therapeutics is looking to bring better and safer T-cell therapies for both solid tumors and blood cancers and has scored a $100 million series A to propel it on its journey.See details»
Tmunity Stock - Company Profile, Valuation, Market Activity, …
About Tmunity Tmunity is a biotherapeutics company that offers a platform for cell immunotherapy, featuring innovative T-cell receptor technology and proprietary methods for …See details»
Tmunity raises funding to advance cancer-fighting cellular therapies
Nov 1, 2019 Tmunity raises funding to advance cancer-fighting cellular therapies. US-based Tmunity Therapeutics has raised a $75m Series B financing led by venture capital firm …See details»
Home | Tunity
Tunity is used by people at bars, restaurants, gyms, universities, doctor’s offices, airports and even at home to enjoy listening to TVs from their mobile devices. Based in New York City, …See details»